14/11/2024  17:38:13 Chg. +0.1700 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
57.5700USD +0.30% 200
Turnover: 11,514
-Bid Size: - -Ask Size: - 15.74 bill.USD - -

Business description

Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
 

Management board & Supervisory board

CEO
Ester Baiget
Management board
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø
Supervisory board
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James
 

Company data

Name: Novozymes A.S
Address: Krogshoejvej 36,DK-2880 Bagsvaerd
Phone: +45-44-460000
Fax: -
E-mail: -
Internet: www.novozymes.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 31/12
Free Float: 74.50%
IPO date: 20/11/2000

Investor relations

Name: Tobias Cornelius Björklund
IR phone: +45-3077-8682
IR Fax: -
IR e-mail: NovozymesIR@novozymes.com

Main Shareholders

Others
 
70.80%
Novo Holdings A/S
 
29.20%